QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Peng, J. Z. Articles by Sawchuk, R. J. Search for Related Content PubMed PubMed Citation Articles by Peng, J. Z. Articles by Sawchuk, R. J.

INHIBITION OF MURINE CYTOCHROME P4501A BY TACRINE: IN VITRO STUDIES

Department of Pharmaceutics (J.Z.P, R.J.S.) and Department of Medicinal Chemistry (R.P.R.), College of Pharmacy, University of Minnesota, Minneapolis, Minnesota

Tacrine, a cholinesterase inhibitor, was approved for the treatment of Alzheimer's disease. Oxidative metabolism of tacrine occurs by CYP1A-catalyzed hydroxylation. In rats, it was observed that the area under the curve (AUC) of the second oral dose was consistently higher than the AUC after the first oral dose, which was not due to the accumulation of the drug in the plasma from the first dose. This finding suggested inhibition of the enzyme during metabolism or inhibition by a metabolite. The inhibitory mechanism was studied in liver and intestinal microsomes prepared from 3-methylcholanthrene-treated rats and with recombinant CYP1A1 and CYP1A2. Preincubation of CYP1A2 with tacrine and NADPH revealed a time-dependent inhibition of 7-ethoxyresorufin O-de-ethylation with a K_i of 1.94 µM and a k_inact of 0.091 min^-1. No time-dependent inhibition was observed with CYP1A1 or with 1-hydroxytacrine or 2-hydroxytacrine. Tacrine metabolism catalyzed by CYP1A was also carried out, and the partition ratio was estimated to be 22. A modified Michaelis-Menten equation involving mechanism-based inhibition was derived and used to analyze the data. Reasonable parameter fits were obtained indicating that this equation is suitable to describe metabolism data when the substrate is a mechanism-based inhibitor of the enzyme. The probable inactivation mechanism involves either hydrogen atom abstraction to produce a carbon-centered radical intermediate at the benzylic position or insertion of OH⁺ into a C-H bond with subsequent loss of water to produce a carbocation. Rapid rearrangement of the carbocation or radical and subsequent covalent binding of the tacrine moiety would result in enzyme inactivation.

This article has been cited by other articles:

				J. H. Lee, Y. K. Cho, Y. S. Jung, Y. C. Kim, and M. G. Lee Effects of Escherichia coli Lipopolysaccharide on Telithromycin Pharmacokinetics in Rats: Inhibition of Metabolism via CYP3A Antimicrob. Agents Chemother., March 1, 2008; 52(3): 1046 - 1051. [Abstract] [Full Text] [PDF]

				M. I. Jushchyshyn, J. L. Wahlstrom, P. F. Hollenberg, and L. C. Wienkers Mechanism of Inactivation of Human Cytochrome P450 2B6 by Phencyclidine Drug Metab. Dispos., September 1, 2006; 34(9): 1523 - 1529. [Abstract] [Full Text] [PDF]